HP and metabolic syndrome: Decreased diversity in gut and esophageal microbial communities, often driven by Hp, reflux-mediated dysbiosis, MetS-related central obesity, administration proton-pump inhibitors and antibiotics, can enhance MC sensitization through microbial-associated molecular patterns (MAMPs) [106,107].